BioMarin Announces That FDA Has Advised it Will Not Take Action on the Kyndrisa™ (drisapersen) New Drug Application by the PDUFA Date
December 18, 2015 at 08:30 AM EST
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the U.S. Food and Drug Administration (FDA) has notified the Company ...